Gendered Innovation Alliance

Welcome! The Gendered Innovation Alliance (GINA) at Karolinska Institutet is a platform for training, knowledge and experience exchange.

Our aim is successful execution for inclusion of concepts of sex, gender and diversity as biological and social variables in biomedical research and education to maximize individualized/personalized patient care and endorse the development of gendered innovations.

For news and updates please follow us on Facebook (KI DEVREG Doctoral Programme & Gendered Innovation Alliance).
We are a part of ACT on gender - collectives of representatives of research and innovation institutions across Europe with a shared domain of interest in advancing the implementation of the European Research Area gender goals.


We imagine a future where gender and diversity dimensions, especially in the research content, are the "new normal". 


How will we make increased gender sensitivity possible?

The framework will provide an infrastructure for robust and effective dissemination of the sex/gender/diversity methods & tools to a scientific community and other target groups. We are aiming to promote scientific excellence and innovation by organising training activities, workshops and scientific meetings, including innovation hubs and sharing best practices.

By participating in ACT on gender, GINA collaborates with research and innovation (R&I) institutions across Europe.

Since sex, gender and diversity interconnects all areas of medical preclinical and clinical research, KI Gendered Innovation Alliance is uniquely set to collaborate broadly across disciplines in strategic partnerships together with industry, health care providers and patient organizations.

Partnerships GINA

Our approach is interdisciplinary and based on 5 pillars (5 Is) torwards innovative thinking:

5 pillars GINA

1. Infrastructure & resources: to distribute knowledge and general capacity building to ensure the alliance’s sustainability for continuous support of strategic/selected areas of research, education and science communication. Together with sex, gender & diversity inclusion we will also disseminate transferrable skills for creativity and complex problem solving such as Design Thinking, Science Communication, Systems Thinking and Future Thinking. Our aim is to empower students and researchers to have the choice to become active agents, game changers and entrepreneurs prepared for the future.
3. Innovation: to stimulate purpose-driven innovative methods, discoveries, treatments in science and medicine. How? By creating connections between academia & the industry and other sectors to increase the societal impact of research and better serve the community. 
2. Integration: to endorse the integration of sex/gender/diversity analysis in medical science and health care. How? By identifying and improving structural barriers and changing attitudes within our research and educational systems and via active promotion of implementation of gender dimension in the research content and educational activities.  
4. Impact: to ensure that new research outcomes using the gender and diversity dimension have measurable and tangible impact on policies, products, services and systems that improve health to everybody. 
5. Internationalisation: to think globally but act locally according to Karolinska Institutet’s strategy for Integration of international perspectives.


Karolina Kublickiene - Programme Director
Phone: +46 (0) 8-585 838 59
Erika Tanos - Communication and Innovation
Phone: +46 (0)70 288 22 34


On the page for education, we are aiming to provide an updated summary of international and national educational activities, towards the implementation of the gender dimension in biomedical research and innovation in healthcare. 

Resources portfolio

Here you can find our innovative Resources portfolio for the implementation of sex, gender & diversity dimension aspects in biomedical research and education. Discover how they add significant value to innovation and become a change maker! 


News & announcements


By participating in ACT on Gender, a Horizon 2020 EU project on gender equality & gender dimension in research, DEVREG is actively working on this.

The report covers the last 20 years, 12 countries and regions, and 27 subject areas. Read and disseminate the report produced by Elsevier and experts from around the world on gender in the global research landscape.


Key findings: 

  • The proportion of women among researchers and inventors is increasing in all twelve comparator countries and regions over time.
  • Women publish fewer research papers on average than men, but there is no evidence that this affects how their papers are cited or downloaded.
  • Women are less likely than men to collaborate internationally on research papers.
  • Women are slightly less likely than men to collaborate across the academic and corporate sectors on research papers.
  • In general, women’s scholarly output includes a slightly larger proportion of highly interdisciplinary research than men’s.
  • Among researchers, women are generally less internationally mobile than men.
  • Gender research is growing in terms of size and complexity, with new topics emerging over time.
  • The former dominance of the United States in gender research has declined as research activity in the European Union has risen.
Zou and Schiebinger (2018), Nature.

Engel, N. (2018), BioEssays: Sex Differences in Early Embryogenesis: Inter‐Chromosomal Regulation Sets the Stage for Sex‐Biased Gene Networks: The dialogue between the sex chromosomes and autosomes imposes sexual identity soon after fertilization. 

Hubs for scientific collaboration

ACT on Gender

Gender Innovation Alliance | DEVREG participates in ACT on Gender - research and innovation (R&I) institutions across Europe advancing the implementation of the European Research Area gender goals. Associated Professor Karolina Kublickiene is the PI from KI. 

Matera Alliance

The Matera Resolution was drafted in April 2016 by an inaugural group of advocates to create a strategy and develop recommendations to improve the evidence base and applicability of drug trial results to women in real world settings. Recent research evidence and the various activities launched with different stakeholders, including regulatory and funding organizations, journal editors, government agencies, industry and patient sectors are discussed. For further inquiries, please contact: Karolina Kublickiene or visit Matera Alliance on FB

CIHR Institute of Gender and Health

The Institute of Gender and Health (IGH)'s mission is to foster research excellence regarding the influence of gender and sex on the health of women and men throughout life, and to apply these research findings to identify and address pressing health challenges. For further inquiries, please contact: Dr Cara Tannebaum

Best practices and publications

Enjoy and learn from recent publications implementing the sex and gender dimension in the research content:

Gender diversity leads to better science by Nielsen et al 2017 
A global call for action to include gender in research impact assessment by Ovseiko PV et al 2016  
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease by Carrero et al 2017 
Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry by Alabas et al 2017 
Gender aspects and innovations:

Forskare: Bilar mindre säkra för halva befolkningen and Forskning på kvinnlig krockdocka gav EU-pris 
For more details follow